Skip to main content

Together we are beating cancer

Donate now

Our milestones

Game-changing research
Showing 6 out of 30 results

We revisit a discovery that spawned a whole new field of cancer research and led to the development of drugs that are used to treat cancer patients today. We revisit a discovery that spawned a whole new field of cancer research and led to the development of drugs that are used to treat cancer patients today.

by Safia Danovi | Analysis | 5 August 2011

5 August 2011

This entry is part 6 of 30 in the series Our milestones

We take a look at the history of the Calvert formula - an equation used all over the world to calculate the required dose of the life-saving drug carboplatin. We take a look at the history of the Calvert formula - an equation used all over the world to calculate the required dose of the life-saving drug carboplatin.

by Kat Arney | Analysis | 21 March 2011

21 March 2011

This entry is part 5 of 30 in the series Our milestones

A step back in time to the 1980s, when one of our scientists helped solve a complex medical mystery with implications for both AIDS and cancer. A step back in time to the 1980s, when one of our scientists helped solve a complex medical mystery with implications for both AIDS and cancer.

by Oliver Childs | Analysis | 22 January 2010

22 January 2010

This entry is part 4 of 30 in the series Our milestones
  • Science & Technology

Discovering the p53 cancer protein

Since its discovery by Professor Sir David Lane in the 1970s, a small molecule called p53 has revolutionised our understanding of how cells grow and divide. Since its discovery by Professor Sir David Lane in the 1970s, a small molecule called p53 has revolutionised our understanding of how cells grow and divide.

by Kat Arney | Analysis | 4 October 2009

4 October 2009

This entry is part 3 of 30 in the series Our milestones
  • Science & Technology

Finding faults in the BRAF gene

Our research sparked a surge of interest in BRAF, a gene that's faulty in more than half of all malignant melanomas, and provided new leads for cancer drugs. Our research sparked a surge of interest in BRAF, a gene that's faulty in more than half of all malignant melanomas, and provided new leads for cancer drugs.

by Kat Arney | Analysis | 24 August 2009

24 August 2009

This entry is part 2 of 30 in the series Our milestones
  • Science & Technology
  • Health & Medicine

CHEKing genes for breast cancer clues

We look at our research into a family’s genes, which revealed a gene fault that may be responsible for a significant minority of inherited breast cancers. We look at our research into a family’s genes, which revealed a gene fault that may be responsible for a significant minority of inherited breast cancers.

by Oliver Childs | Analysis | 23 April 2009

23 April 2009

This entry is part 1 of 30 in the series Our milestones